4-Chloro-7-methoxy-6-(3-morpholinopropoxy)quinazoline (CAS: 199327-59-8) is a specialized heterocyclic organic compound belonging to the quinazoline family. This substance serves as a critical building block in the synthesis of advanced pharmaceutical agents, particularly those targeting specific kinase pathways. Its molecular structure features a chloro-substituted quinazoline core with methoxy and morpholinopropoxy side chains, which are essential for the biological activity of the final molecules derived from this intermediate.
The compound is primarily utilized in research and development and large-scale pharmaceutical manufacturing. As a high-purity intermediate, it ensures the efficiency and quality of downstream chemical reactions. It is handled as a stable solid under recommended storage conditions, typically requiring protection from moisture and light to maintain its chemical integrity throughout the synthesis process. Its role is pivotal in the production of selective inhibitors used in targeted therapies.